glutathione cancer patients A study shows that the antioxidant feeds cells Application of glutathione depletion in
Description
Second, GHK-Cu has a short half-life in tissue, less than one hour in serum according to pharmacokinetic studies
2008 Jul
-Fabian Let's be clear - we can not confirm nor deny long-term risk including cancer risk with BPC or TB-500
When it came to analysing their results with the Poisson method, Delbrck and Luria argued 'The situation is similar to the operation of a (fair) slot machine, where the average return from a limited number of plays is probably considerably less than the input, and improbably, when the jackpot is hit, the return is much bigger than the input' (Luria, Delbrck)
If you want quick answers to common product questions, review our FAQ
BPC-157 is sold strictly as a research compound and is not approved for human use
